Priority Date: 17.02.12 (US 201261600196P)
DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
- Application ID: EP13749397
- Status: █ EXAMINATION IN PROGRESS
Applicant
Technology Company
Attorney
Specialization
This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Merck & Co. Inc. is specialized in A61. Merck & Co. Inc. is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.
Timeline
- 17.02.2012 - Priority Date (US 201261600196P)
- 22.08.2013 - Publication A1 (WO2013122920)
- 24.12.2014 - Publication A1 (EP2814485)